Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors

R. von Wasielewski, S. Seth, J. Franklin, R. Fischer, K. Hübner, M. L. Hansmann, V. Diehl, A. Georgii

Blood (2000) 95 (4): 1207–1213.

https://doi.org/10.1182/blood.V95.4.1207.004k34_1207_1213

Published: 2000

Journal Articles

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

U. Winkler, M. Jensen, O. Manzke, H. Schulz, V. Diehl, A. Engert

Blood (1999) 94 (7): 2217–2224.

https://doi.org/10.1182/blood.V94.7.2217.419k02_2217_2224

Published: 1999

Journal Articles

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Blood (1998) 92 (12): 4560–4567.

https://doi.org/10.1182/blood.V92.12.4560

Published: 1998

Journal Articles

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

B. Coiffier, C. Haioun, N. Ketterer, A. Engert, H. Tilly, D. Ma, P. Johnson, A. Lister, M. Feuring- Buske, J.A. Radford, R. Capdeville, V. Diehl, F. Reyes

Blood (1998) 92 (6): 1927–1932.

https://doi.org/10.1182/blood.V92.6.1927

Published: 1998

Journal Articles

Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells

J Wolf, U Kapp, H Bohlen, M Kornacker, C Schoch, B Stahl, S Mucke, C von Kalle, C Fonatsch, HE Schaefer, ML Hansmann, V Diehl

Blood (1996) 87 (8): 3418–3428.

https://doi.org/10.1182/blood.V87.8.3418.bloodjournal8783418

Published: 1996

Journal Articles

Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed- Sternberg cells of a Hodgkin's lymphoma patient

H Kanzler, ML Hansmann, U Kapp, J Wolf, V Diehl, K Rajewsky, R Kuppers

Blood (1996) 87 (8): 3429–3436.

https://doi.org/10.1182/blood.V87.8.3429.bloodjournal8783429

Published: 1996

Journal Articles

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins

U Winkler, C Gottstein, G Schon, U Kapp, J Wolf, ML Hansmann, H Bohlen, P Thorpe, V Diehl, A Engert

Blood (1994) 83 (2): 466–475.

https://doi.org/10.1182/blood.V83.2.466.466

Published: 1994

Journal Articles

Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies

H Bohlen, T Hopff, O Manzke, A Engert, D Kube, PD Wickramanayake, V Diehl, H Tesch

Blood (1993) 82 (6): 1803–1812.

https://doi.org/10.1182/blood.V82.6.1803.1803

Published: 1993

Journal Articles

Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma

J Delabie, R Shipman, J Bruggen, B De Strooper, F van Leuven, L Tarcsay, N Cerletti, K Odink, V Diehl, G Bilbe

Blood (1992) 80 (11): 2891–2896.

https://doi.org/10.1182/blood.V80.11.2891.2891

Published: 1992

Journal Articles

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

A Gause, C Pohl, A Tschiersch, L Da Costa, W Jung, V Diehl, D Hasenclever, M Pfreundschuh

Blood (1991) 77 (9): 1983–1988.

https://doi.org/10.1182/blood.V77.9.1983.1983

Published: 1991

Journal Articles

L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor

I Katay, U Wirnitzer, H Burrichter, C von Kalle, E Schell-Frederick, V Diehl, M Schaadt

Blood (1990) 76 (4): 791–796.

https://doi.org/10.1182/blood.V76.4.791.791

Published: 1990

NARROW

Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

Moderate Dose Escalation for Advanced Stage Hodgkin’s Disease Using the Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, and Prednisone Scheme and Adjuvant Radiotherapy: A Study of the German Hodgkin’s Lymphoma Study Group

Rituximab (Anti-CD20 Monoclonal Antibody) for the Treatment of Patients With Relapsing or Refractory Aggressive Lymphoma: A Multicenter Phase II Study

Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells

Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed- Sternberg cells of a Hodgkin's lymphoma patient

Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins

Lysis of malignant B cells from patients with B-chronic lymphocytic leukemia by autologous T cells activated with CD3 x CD19 bispecific antibodies in combination with bivalent CD28 antibodies

Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

L428 cells derived from Hodgkin's disease produce E rosette-inhibiting factor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only